Funding to advance novel Hepatitis C Virus (HCV) therapies against new targets PALO ALTO, Calif., Feb. 26 (HSMN NewsFeed) — Eiger BioPharmaceuticals, Inc., a start-up biotechnology company developing antiviral therapies, announced that it has raised …
Biopharmaceuticals, Venture Capital
Eiger BioPharmaceuticals, hepatitis

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Eiger BioPharmaceuticals Raises $7.1 Million’A’ Round”
Leave a Comment